Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics and individualized dosing of lobaplatin regimens in elderly patients with small cell lung cancer
ChiCTR-OPN-15006057Phase 4Recruiting
- Sponsor
- Jilin Provincial Cancer Hospital
- Start
- May 2014
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lobaplatin in small cell lung cancer (SCLC), sponsored by Jilin Provincial Cancer Hospital. Primary endpoint: Blood and plasma concentration of lobaplatin at each time point. Started May 2014; status: recruiting.
02
Drugs
lobaplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR-OPN-15006057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-15006057.